FDA Commissioner-Nominee Gottlieb Pressed More On Drug Development Than Industry Ties
Executive Summary
Scott Gottlieb's industry connections were expected to be a major focus of his US Senate confirmation hearing. However, our analysis of the questions asked show drug development was the top priority.